You are here

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Kynurenine pathway is altered in patients with SLE and associated with severe fatigue

https://doi.org/10.1136/lupus-2017-000254corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Åkesson K, Pettersson S, Ståhl S, et al. Kynurenine pathway is altered in patients with SLE and associated with severe fatigue. Lupus Science & Medicine 2018;5:e000254. doi: 10.1136/lupus-2017-000254

    The authors want to alert readers to the following two errors identified in the published version.

    The second sentence in the Conclusions section of the Abstract should read as:

    Drugs targeting enzymes in the kynurenine pathway, for example, IDO inhibitors or niacin (B3) supplementation, which suppresses IDO activity, merit further investigation as treatments in SLE.

    Again, in the Discussion section, the last sentence of the second paragraph should read as:

    In the aim to suppress IDO activity, niacin (vitamin B3) supplementation9 and IDO blockers43 might be interesting treatment perspectives in SLE.